Jake Bauer
Director/Board Member presso ENLIVEN THERAPEUTICS, INC.
Patrimonio netto: 2 M $ in data 31/03/2024
Profilo
Jake Bauer is currently the Chairman at Simcha Therapeutics, Inc. and Simcha Therapeutics Holding Co. LLC.
He is also the Director at Enliven Therapeutics, Inc. and Independent Director at Attralus, Inc., ARYA Sciences Acquisition Corp.
V, and Enliven Therapeutics, Inc. Additionally, he serves as a Venture Partner at SR One Capital Management LP, ARCH Venture Partners LLC, and GSK Equity Investments Ltd.
In the past, Mr. Bauer held positions as an Independent Director at ARYA Sciences Acquisition Corp.
II, Principal at Zafgen, Inc., VP-Business Operations & Head-Development at Ablexis LLC, Chief Business Officer at MyoKardia, Inc., and Principal at Global Blood Therapeutics, Inc. He also worked as a Consultant at Bristol Myers Squibb Co., Principal at Royalty Pharma Cayman Partners LP, and Senior Associate at Third Rock Ventures LLC.
Furthermore, he was a Management Consultant at Putnam Associates LLC, Principal at Endo Health Solutions, Inc., Principal at CytomX LLC, Principal at Agios Pharmaceuticals, Inc., and Principal at Third Rock Ventures LLC.
Mr. Bauer completed his undergraduate degree at Duke University in 2001 and obtained an MBA from Harvard Business School in 2007.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
13/02/2024 | 87 372 ( 0.21% ) | 2 M $ | 31/03/2024 |
Posizioni attive di Jake Bauer
Società | Posizione | Inizio |
---|---|---|
ARYA SCIENCES ACQUISITION CORP V | Director/Board Member | 01/07/2021 |
ENLIVEN THERAPEUTICS, INC. | Director/Board Member | 23/02/2023 |
Phoenix Tissue Repair, Inc.
Phoenix Tissue Repair, Inc. Pharmaceuticals: MajorHealth Technology Part of BridgeBio Pharma, Inc., Phoenix Tissue Repair, Inc. develops biopharmaceuticals. The private company is based in Boston, MA. | Director/Board Member | 01/11/2018 |
SR One Capital Management LP
SR One Capital Management LP Investment ManagersFinance SR One Capital Management LP (SR One) is a venture capital firm founded in 2020. The firm is headquartered in Redwood, California. | Private Equity Investor | - |
Simcha Therapeutics Holding Co. LLC
Simcha Therapeutics Holding Co. LLC BiotechnologyHealth Technology Simcha Therapeutics Holding Co. LLC is a biopharmaceutical company which engages in developing an engineered interleukin therapy. The company was founded in 2018 and is headquartered in New Haven, CT. | Chairman | - |
Simcha Therapeutics, Inc.
Simcha Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Simcha Therapeutics, Inc. operates as a biopharmaceutical company that develops engineered interleukin therapy products. The company was founded by Aaron Ring in 2018 and is headquartered in New Haven, CT. | Chairman | 01/01/2022 |
GSK Equity Investments Ltd.
GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity Investment Ltd (GSK Equity) is a venture capital firm a subsidiary of GlaxoSmithKline Plc founded in 1985. The firm is headquartered in Reedwood City, California. | Private Equity Investor | - |
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Private Equity Investor | 01/12/2021 |
Attralus, Inc.
Attralus, Inc. Pharmaceuticals: MajorHealth Technology Attralus, Inc. operates as a biopharmaceutical company. The firm focuses on illuminating the systemic nature of amyloidosis and creating transformative medicines to improve the lives of patients. The company was founded by Jonathan Wall in 2019 and is headquartered in San Francisco, CA. | Director/Board Member | 28/07/2021 |
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Precedenti posizioni note di Jake Bauer
Società | Posizione | Fine |
---|---|---|
░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░ | ░░░░░░░░░░ ░ ░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Jake Bauer
Duke University | Undergraduate Degree |
Harvard Business School | Masters Business Admin |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
AGIOS PHARMACEUTICALS, INC. | Health Technology |
ENLIVEN THERAPEUTICS, INC. | Health Technology |
Aziende private | 19 |
---|---|
Endo Health Solutions, Inc.
Endo Health Solutions, Inc. Pharmaceuticals: MajorHealth Technology Endo Health Solutions, Inc. operates as holding company with interest in providing health care services. It offers pain management, pelvic health, urology, endocrinology and oncology services. The company was founded by Carol A. Ammon on November 18, 1997 and is headquartered in Malvern, PA. | Health Technology |
ARCH Venture Partners LLC
ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Finance |
Zafgen, Inc.
Zafgen, Inc. BiotechnologyHealth Technology Zafgen, Inc. is a biopharmaceutical company, which engages in the development of novel therapies for patients affected by complex metabolic diseases. It focuses on the study of MetAP2 inhibitors in both common and rare metabolic disorders. The firm also advancing programs for type 2 diabetes, Prader-Willi syndrome, and liver diseases. The company was founded on November 22, 2005 and is headquartered in Boston, MA. | Health Technology |
Royalty Pharma Cayman Partners LP
Royalty Pharma Cayman Partners LP Pharmaceuticals: MajorHealth Technology Royalty Pharma Cayman Partners LP develops pharmaceutical products. The firm distributes products to hospitals, health care centers, medical outlet stores and other institutes. The company is located in New York, NY. | Health Technology |
MyoKardia, Inc.
MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology MyoKardia, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, commercialization, and development of therapies for the treatment of cardiovascular diseases. Its lead therapeutic candidate, Mavacamten, is an orally administered allosteric modulator of cardiac myosin being developed for the treatment of hypertrophic cardiomyopathy (HCM). The company was founded by James A. Spudich, Jonathan G. Seidman, Christine Seidman, and Leslie Leinwand on June 8, 2012 and is headquartered in South San Francisco, CA. | Health Technology |
GSK Equity Investments Ltd.
GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity Investment Ltd (GSK Equity) is a venture capital firm a subsidiary of GlaxoSmithKline Plc founded in 1985. The firm is headquartered in Reedwood City, California. | Finance |
CytomX LLC
CytomX LLC Medical SpecialtiesHealth Technology CytomX LLC develops protein therapeutics and integrated medical diagnostic devices. It provides molecular engineering and micro fluidic cell separation technologies. The company was co-founded by Dr. Hyongsok Soh, Dr. Alan J. Heeger, and Dr. Patrick S. Daugherty in 2006 and is headquartered in Santa Barbara, CA | Health Technology |
Putnam Associates LLC
Putnam Associates LLC Miscellaneous Commercial ServicesCommercial Services Putnam Associates LLC engages in the provision of strategic consulting serving biopharmaceutical, diagnostics, and medical device clients. It specializes in corporate strategy, portfolio licensing and development strategy, new product, established products and franchise strategy, pricing, reimbursement and market access, and other related strategic projects. The company was founded by Kevin J. Gorman in 1988 and is headquartered in Boston, MA. | Commercial Services |
Simcha Therapeutics Holding Co. LLC
Simcha Therapeutics Holding Co. LLC BiotechnologyHealth Technology Simcha Therapeutics Holding Co. LLC is a biopharmaceutical company which engages in developing an engineered interleukin therapy. The company was founded in 2018 and is headquartered in New Haven, CT. | Health Technology |
Phoenix Tissue Repair, Inc.
Phoenix Tissue Repair, Inc. Pharmaceuticals: MajorHealth Technology Part of BridgeBio Pharma, Inc., Phoenix Tissue Repair, Inc. develops biopharmaceuticals. The private company is based in Boston, MA. | Health Technology |
Simcha Therapeutics, Inc.
Simcha Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Simcha Therapeutics, Inc. operates as a biopharmaceutical company that develops engineered interleukin therapy products. The company was founded by Aaron Ring in 2018 and is headquartered in New Haven, CT. | Health Technology |
Enliven Therapeutics, Inc. /US/
Enliven Therapeutics, Inc. /US/ BiotechnologyHealth Technology EnLiven Therapeutics, Inc. engages in the discovery and development of small molecule treatments for cancer. The company was founded by Samuel S. Kintz and is headquartered in San Francisco, CA. | Health Technology |
SR One Capital Management LP
SR One Capital Management LP Investment ManagersFinance SR One Capital Management LP (SR One) is a venture capital firm founded in 2020. The firm is headquartered in Redwood, California. | Finance |
ARYA Sciences Acquisition Corp. II
ARYA Sciences Acquisition Corp. II Financial ConglomeratesFinance ARYA Sciences Acquisition Corp. II is blank check company which formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities, which refer to as its initial business combination. The company was founded by Joseph Edelman, Adam Stone & Michael Altman on February 20, 2020 and is headquartered in New York, NY. | Finance |
Attralus, Inc.
Attralus, Inc. Pharmaceuticals: MajorHealth Technology Attralus, Inc. operates as a biopharmaceutical company. The firm focuses on illuminating the systemic nature of amyloidosis and creating transformative medicines to improve the lives of patients. The company was founded by Jonathan Wall in 2019 and is headquartered in San Francisco, CA. | Health Technology |
ARYA Sciences Acquisition Corp. V
ARYA Sciences Acquisition Corp. V Financial ConglomeratesFinance Arya Sciences Acquisition Corp. V is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Adam Stones, Joseph Eric Edelman, Michael R. Altman, and Konstantin Poukalov on February 22, 2021 and is headquartered in New York, NY. | Finance |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Finance |
Ablexis LLC
Ablexis LLC Packaged SoftwareTechnology Services Ablexis LLC develops next-generation platform for antibody drug discovery. It develops the AlivaMab Mouse, an innovative, next-generation transgenic mouse platform intended to enable the efficient discovery and development of the next generation of human therapeutic antibodies. The company was founded by Green L. Larry and Hiroaki Shizuya in December 2009 and is headquartered in Burlingame, CA. | Technology Services |
Global Blood Therapeutics, Inc.
Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Jake Bauer